TrialTrove Software Subscription
Closed Solicitation Posted
- Solicitation number
- 75N98026Q00035
- Agency
- Office of the Assistant Secretary for Administration Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 513210 Software Publishers
- PSC
- 7H20 It And Telecom - Platform Products: Database, Mainframe, Middleware (Hw, Perpetual License Software)
- Place of performance
- Rockville, Maryland 20857, United States
- Points of contact
-
- Vera Nordalm vera.nordalm@hhs.gov (301) 348-3592
- Kwasi Antwi kwasi.antwi@hhs.gov (202) 394-2580
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Logistics and Office of Administration, is soliciting a commercial Software as a Service (SaaS) subscription to the TrialTrove clinical trials database to support oncology research activities conducted by the National Cancer Institute's Cancer Data Science Laboratory. This Request for Quotation (RFQ) is being conducted under FAR Part 12 commercial item procedures and FAR Part 13 simplified acquisition procedures using a brand name specification for competitive procurement. Key contract requirements include providing access to a curated global clinical trials database with minimum daily updates (Monday through Friday), support for bulk data downloads and static data snapshots for longitudinal analysis, robust biomarker and genomic data fields, publication rights for derived research findings, two user licenses with access credentials within one business day of award, live virtual end-user training within ten business days of license activation, and comprehensive technical support services including email, telephone, and an "Ask the Analyst" feature. The evaluation method will utilize the Lowest Priced Technically Acceptable (LPTA) approach. The deadline for submitting questions is February 20, 2026 at 2:00 PM EST, and quotes must be received no later than February 23, 2026 at 2:00 PM EST, with all submissions directed to Vera Nordalm and copied to Kwasi Antwi at the HHS email addresses provided.
This procurement includes no small business set-aside designation and is an unrestricted full and open competition. The contract will span a 12-month base period from February 27, 2026 through February 26, 2027, with four optional one-year renewal periods extending through February 26, 2031. The product/service code is classified as 7H20 (IT and Telecom - Platform Products) with NAICS code 513210 (Software Publishers). The requirement specifies a Multi-User License Seat for Online Database access with two concurrent user licenses. Payment will be made monthly in arrears through the Department of Treasury's Invoice Processing Platform in accordance with the Prompt Payment Act and FAR 32.905(b). The place of performance is Rockville, Maryland 20857, with the contracting officer identified as Kwasi B. Antwi. The government has provided a brand name justification indicating that the Cancer Data Science Laboratory has made substantial multi-year investments in analytical tools and workflows specifically designed for TrialTrove data, making transition to alternative systems operationally disruptive.
Notice text
This combined synopsis/solicitation is a Request for Quotation (RFQ) prepared utilizing FAR Part 12 commercial item procedures and simplified acquisition procedures under FAR Part 13. This announcement constitutes the only solicitation. Quotes are being requested, and a separate written solicitation will not be issued.
This acquisition is being conducted as a full and open competition using competitive procedures, with a brand name specification in accordance with FAR 13.106-1(b).
This solicitation incorporates provisions and clauses by reference. The full text of provisions and clauses may be accessed electronically at https://www.acquisition.gov and https://www.acquisition.gov/hhsar. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC(FAC) 2025-06 October 1, 2025.
All questions and inquiries concerning this solicitation must be submitted by e-mail only (no faxes or telephone calls will be accepted) to the Contract Specialist no later than February 20th, 2026 at 2:00pm Eastern Standard Time (EST). Questions must be emailed to the following addresses: Vera Nordalm via Vera.Nordalm@hhs.gov, and copy Kwasi Antwi at Kwasi.Antwi@hhs.gov and must reference “TrialTrove Software Subscription – RFQ 75N98026Q00035 in the subject line.
Quotes must be received no later than February 23rd, 2026 at 2:00pm Eastern Standard Time (EST). Offerors must submit their quote to the following addresses: Vera Nordalm via Vera.Nordalm@hhs.gov, and copy Kwasi Antwi at Kwasi.Antwi@hhs.gov and must reference “TrialTrove Software Subscription – RFQ 75N98026Q00035 in the subject line.
This requirement is for a commercial Software as a Service (SaaS) subscription to the TrialTrove clinical trials database, to support oncology research activities conducted by the National Cancer Institute, Center for Cancer Research, Cancer Data Science Laboratory (CDSL). The TrialTrove database enables sophisticated querying and analysis across a wide range of clinical trial attributes, including disease indications, treatments, trial phase, sponsors, eligibility criteria, endpoints, outcomes, and trial timelines. TrialTrove also provides curated narratives of trial results and cross-references to original source materials, allowing researchers to validate and contextualize trial data. These capabilities are critical to CDSL’s mission and are not available through publicly accessible clinical trial databases.
Please refer to the attached solicitation documents for the complete description of requirements.
Attachments
| File | Type | Posted |
|---|---|---|
| Brand Name Justification.pdf | ||
| RFQ 75N98026Q00035.pdf | ||
| Attachment A - Statement of Work (SOW).pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity